Reviewing the Evidence for De Novo Immunosuppression With Sirolimus

Transplantation Proceedings

Volumn 40, Issue 10 SUPPL., 2008, Pages

  Flechner, S M ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ANEMIA; ARTICLE; DRUG MECHANISM; DRUG SUBSTITUTION; DYSLIPIDEMIA; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCELE; MOUTH ULCER; NEPHROTOXICITY; OLIGOANURIA; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; RASH; RISK; THROMBOCYTOPENIA; TUBULAR ATROPHY; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

CALCINEURIN; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS;

EID: 57649105495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.013     Document Type: Article

References (28)

1. 2007 OPTN/SRTR Annual Report: Tables 1.11a. http://www.optn.org/AR2007/111a_dh.htm Accessed June 30, 2008
2. Rush D., Arlen D., Boucher A., et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 7 (2007) 2538
3. Kandaswamy R., Melancon J.K., Dunn T., et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant 5 (2005) 1529
4. Meier-Kriesche H.-U., Schold J.D., Srinivas T.R., et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4 (2004) 378
5. Marcen R., Pascual J., Teruel J.L., et al. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?. Transplantation 72 (2001) 57
6. Gallagher M.P., Hall B., Craig J., et al. A randomized trial of cyclosporine withdrawal in renal-transplantation recipients: 15-year results. Transplantation 78 (2004) 1653
7. Nankivell B.J., Borrows R.J., Fung C.L.-S., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
8. Solez K., Vincenti F., and Filo R.S. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 66 (1998) 1736
9. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
10. 2006 OPTN/SRTR Annual Report: Tables 5.6d. http://www.ustransplant.org/annual_Reports/archives/2006/default.htm Accessed June 30, 2008
11. Rowshani A.T., Scholten E.M., Bemelman F., et al. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol 17 (2006) 305
12. Vincenti F., Ramos E., Brattstrom C., et al. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 71 (2001) 1282
13. Morales J.M., Wramner L., Kreis H., et al. Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2 (2002) 436
14. Groth C.G., Backman L., Morales J.M., et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Transplantation 67 (1999) 1036
15. Kreis H., Cisterne J.M., Land W., et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 69 (2000) 1252
16. Flechner S.M., Goldfarb D., Modlin C., et al. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 74 (2002) 1070
17. Flechner S.M., Kurian S.M., Solez K., et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 4 (2004) 1776
18. Flechner S.M., Goldfarb D., Solez K., et al. Kidney transplantation with sirolimus and MMF based immunosuppression: 5-year results of a randomized prospective trial compared to CNI drugs. Transplantation 83 (2007) 883
19. Hamdy A.F., El-Agroudy A.E., Bakr M.A., et al. Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant 5 (2005) 2531
20. Lo A., Egidi M.F., Gaber L.W., et al. Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation 77 (2004) 1228
21. Buchler M., Caillard S., Barbier S., et al. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin®, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant 7 (2007) 2522
22. Larson T.S., Dean P.G., Stegall M.D., et al. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 6 (2006) 514
23. Schaffer H.M., Kizilisik A.T., Feurer I., et al. Short-term results under three different immunosuppressive regimens at one center. Transplant Proc 38 (2006) 3464
24. Martinez-Mier G., Mendez-Lopez M., Budar-Fernandez L., et al. Living related kidney transplantation without calcineurin inhibitors: initial experience in a Mexican center. Transplantation 82 (2006) 1533
25. Webster A.C., Lee V.W.S., Chapman J.R., et al. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation 81 (2006) 1234
26. Letavernier E., Peraldi M.N., Pariente A., et al. Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation 80 (2005) 1198
27. Tiong H.Y., Flechner S.M., Zhou L.M., et al. A systematic approach to minimizing wound problems for de novo sirolimus treated kidney transplant recipients. Transplantation (2008) (in press)
28. Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357 (2007) 2562